Commensal microbes in the gut do not act alone but instead as cooperative consortia to 23 conduct their myriad functions. Cooperative interactions and feedback mechanisms are 24 key to consortia performance, yet are often ignored in current synthetic biology efforts to 25 engineer the microbiota. To this end, we engineered mutual metabolic dependencies 26 between four heterogeneous gut-dwelling bacterial species. Each species was made 27 auxotrophic for three amino acids and an overproducer for one amino acid to share with 28 the other species. By performing dynamical systems inference from time-series 29 measurements, we show that our engineering introduced positive interactions that either 30 reversed or neutralized pre-existing competitive interactions and improved stability of 31 the consortium. We further demonstrate that we can induce population balance in the 32 engineered consortia, both in vitro and in the mouse gut, through nutrient and dietary 33 manipulations. Our findings indicate that induced cooperation can introduce evenness 34 and stability in a synthetic microbial ecosystem, and have implications for development 35 of synthetic approaches to manipulate the microbiome.
Introduction 53
In nature, microbes occur as conglomerates of various species with diverse sets of 54 genomes and metabolic capabilities, allowing for division of labor and increased 55 robustness (Hays et al., 2015a) . For example, microbial consortia have been shown to 56
withstand external perturbations such as invasion of other species, toxic compounds 57 and nutrient sparseness (Burmølle et al., 2006; Lapara et al., 2002) . A major driver for 58 microbial consortia robustness is cooperative behavior through production of public 59 goods and metabolic cross-feeding (Cavaliere et al., 2017) . Consortia robustness is 60 correlated with population balance among the microbes and an extensive network of 61 interactions between species (Stelling et al., 2004; Stenuit and Agathos, 2015) . overflow, which leads to natural cross-feeding to lactic acid bacteria (Ponomarova et al., 79 engineered consortium exhibits population balance that is stable when subjected to 115 perturbations in vitro and when introduced into the mammalian gut. 116
117

Results
118
Cooperative Consortia Design and Engineering 119
To gain intuition into synthetic consortia designs, we simulated behavior of non-120 interacting collections of four bacterial species versus consortia linked by 121 positive/cooperative interactions ( Figure 1A ). Our simulations demonstrate that while a 122 collection of non-interacting bacteria can exhibit population balance, it is highly 123 susceptible to external disturbances that can drastically change the composition of the 124 community. In particular, disturbances can readily cause a species to die out in the 125 community. However, when we linked bacterial species through cooperative 126 interactions, the resulting consortia can withstand much higher levels of external 127 disturbances without dramatically altering its composition. Thus, our simulations 128 suggest that engineering a network of positive interactions within a bacterial consortium 129 could introduce stability towards environmental disturbances. 130
131
To construct our synthetic consortium, we selected four bacterial species, Escherichia 132 coli NGF-1, Salmonella enterica subsp enterica serovar Typhimurium LT2, Bacteroides 133 thetaiotaomicron VPI-5482, and Bacteroides fragilis 638R. These species are not only 134 genetically tractable, but also able to survive in the mammalian gut in diverse niches 135 and have varied abundances within the total microbiota. These characteristics allow us 136 to investigate key synthetic biology engineering principles in a controlled, but more 137 realistic context, and also maximize potential for downstream applications, for example 138 for bacterial therapeutics and diagnostics in the gut. 139 140 E. coli NGF-1 was isolated from BALB/c mice, has been shown to stably colonize the 141 mouse gut, and can be engineered with standard genetic tools (Kotula et al., 2014 ; 142 Riglar et al., 2017) . S. Typhimurium LT2 was further attenuated by removing the 143 pathogenicity islands SPI1 and SPI2, and thus did not cause any disease phenotype 144 when administered to mice. The two Bacteroides species, Bacteroides thetaiotaomicron 145
and Bacteroides fragilis, are human commensals that can achieve high abundance in 146 the mammalian gut, and are also genetically tractable. 147
148
We engineered each of the constituent species to depend on the other three by cross-149 feeding of the four metabolites L-methionine, L-histidine, L-tryptophan and L-arginine 150 (hereafter referred to as Met, His, Trp and Arg) ( Figure 1B ). Auxotrophies for three of 151 these amino acids were generated in each strain (E. coli: His, Trp 
Characterization of Auxotrophies and Overproduction 165
To assess the auxotrophic strains' amino acid requirements, we measured growth on 166 varying concentrations of each metabolite in the presence of non-limiting concentrations 167 of all the other metabolites ( Figure 2A) . Each strain had a requirement for specific and 168 differing levels of the amino acids. Overproduction of metabolites was measured in 169 comparison to a defined amino acid standard using LC-MS (Figure 2A, horizontal bars) . 170
In order to compare overproduction with each species' amino acid requirements, we fit a 171 sigmoidal curve to the growth response data (Figure 2A) , to produce an expected 172 concentration (OD600) for the species for a given overproduction rate. This comparison 173 of requirements and overproduction levels provides information about the expected 174 relative strengths of the engineered interactions. 175
176
By comparing growth of strains in monoculture to the full consortium co-culture, we can 239 assess the degree of cooperativity in the bacterial community. We quantify this behavior 240 using a cooperation factor, defined as the total concentration of the co-culture divided 241 by the sum of the concentrations of the monocultures. According to this definition, a 242 cooperation factor <1 indicates competitive behavior, whereas a cooperation factor of 243 >1 indicates cooperation. For the WT consortium, each of the strains grew better in 244 monoculture than in co-culture ( Figure 3B) , with a cooperation factor of 0.14. This 245 finding suggests pre-existing negative interactions among the WT species, e.g., 246
competition for nutrients or production of compounds toxic to the other species. For the 247 engineered consortia, the cooperation factor is 1.18, indicating that our engineering 248 strategy has led to a net growth improvement when the complete consortium is able to 249 interact. Note that much of the growth improvement is due to E. coli and S. 250
Typhimurium growth, whereas B. theta and B. fragilis growth is essentially unchanged. 251
This suggests that our engineering introduced net positive interactions for E. coli and S. 252
Typhimurium, while neutralizing competitive effects on B. theta and B. fragilis present in 253 the WT consortium. 254
255
Since our engineering design is based on amino-acid cross-feeding, we hypothesized 256 that by varying the concentrations of amino acids in the medium, we could control the 257 degree of cooperativity among the consortium members. To test this hypothesis, we 258 subjected the engineered bacteria in monoculture and co-culture to different 259 concentrations of relative amino acid supplementation ( Figure 3C ). We measured 260 bacterial abundance (cfu/mL) via qPCR after 24 hr and calculated cooperation factors 261 for each condition. Overall, bacterial growth decreases for both monoculture and co-262 culture conditions with decreasing supplementation, as expected. Interestingly, we were 263 effectively able to ablate cooperativity with high amino acid supplementation; in this 264 regime, the engineered consortium behaves like the WT consortium, with monoculture 265 growth exceeding co-culture growth. As supplementation decreased, we found that the 266 cooperativity factor consistently increased, with the factor exceeding 1 at a 267 supplementation level of 3 uM. These findings are consistent with cross-feeding 268 behavior in naturally occurring microbial consortia, in which cooperativity only occurs 269 during nutrient scarcity (Carlson et al., 2018) . 270
271
Our simulation studies showed that our engineering design could result in a consortium 272 with a balanced population less susceptible to environmental changes. Thus, we were 273 interested in how varying amino acid supplementation would affect population balance. 274
To assess this, we measured relative abundances of each species in the engineered 275 consortium ( Figure 3C , lower panel) via strain-specific qPCR. We quantitated population 276 balance using the normalized entropy measure (also called the evenness index) for the 277 consortium. With this measure, a completely even (balanced) community would have a 278 relative entropy of one. 279
280
We found that the highest population evenness occurred with the highest 281 supplementation (1000 uM.) This is likely because all the required amino acids are 282 supplied, which reduces competition that would lower population evenness. When 283 supplementation is decreased to intermediate levels (30 and 100 uM), the relative 284 abundances of bacteria become less even, i.e. entropy decreases. Specifically, 285
Bacteroides spp. abundance decreases dramatically, and E. coli and S. Typhimurium 286 dominate the culture. This level of supplementation represents a "mismatched" regime, 287 in which amino acid concentrations are high enough to support some of the species (S. 288
Typhimurium and E. coli, which have the lowest amino acid requirements), but not the 289 others (the Bacteroides spp., which have higher requirements.) When amino acid 290 supplementation is reduced further (particularly below 20 uM), the ecosystem enters a 291 low nutrient regime characterized by increased cooperativity as described above, and 292 population evenness increases again, almost to levels seen with the highest levels of 293
supplementation. 294 295
The Engineered Consortium Exhibits Greater Stability 296
Our amino acid supplementation experiments demonstrated that a microbial consortium 297 with low cooperativity can exhibit high population evenness, but can also be less stable. 298
One measure of stability is the extent to which a system tends to reach the same end-299 point or steady-state, even if it starts in a different initial state. Indeed, this behavior is a 300 necessary condition for common microbial dynamical systems models to exhibit 301 asymptotic stability (Gibson et al., 2017) . To assess the stability of our consortium 302 according to this criteria, we inoculated both WT and engineered consortia at five 303 different starting concentrations each (Figure 4) . In condition 1, all bacterial species 304 were inoculated at the same ratios, and in conditions 2-5, we reduced one of the 305 species' inocula by a factor of 10. We then assessed growth of each strain in co-culture 306 over 12 hours ( Figure 4A , B) via strain-specfic qPCR. Both consortia reached consistent 307 total concentrations at 12 hrs (approximately 5 x 10 7 cfu/mL, 1 x 10 6 cfu/mL for 308 engineered.) However, the end-point abundances of the WT consortium members 309 differed markedly, depending on the starting condition. In particular, for conditions 2-4, 310 the low inoculum species remained low at 12 hrs. In contrast, the engineered 311 Our design created a mutually coupled bacterial consortium designed to function 319 together, suggesting that consortium behavior is best assessed in the full assemblage, 320 rather than through pairwise co-culture experiments. In order to investigate such 321 behavior, we analyzed the densely sampled time-series data from our experiments 322 using the entire consortium with different initial starting conditions (Figures 4A,4B ; 323 described in the previous section) with a dynamical systems inference approach. 324
325
Our dynamical systems approach uses a tailored model based on stochastic 326 generalized Lotka-Volterra (gLV) dynamics and an associated fully Bayesian machine-327 learning/statistical inference algorithm (Methods, Gibson and Gerber, 2018) . Continuous 328 time stochastic generalized Lotka-Volterra (gLV) dynamics can be expressed as: 329
where , ,ℓ is the abundance of microbe at time in experiment ℓ. The parameter 331 denotes the growth rate of microbe , and , is the effect that microbe has on microbe 332
. When = the expression , is a self-limiting term and together with determines 333 the carrying capacity, − , , of microbe if no other microbes were present. Finally, is 334 the process disturbance term, which we assume is a Brownian motion. For inference, 335
we discretize the continuous dynamics as described fully in Methods. 336
337
We used our method to infer growth rates and microbe-microbe interaction strengths 338 from our time-series data ( Figure 4E ,F). As we described above, the WT consortium 339 achieves an overall higher concentration of approximately 5 x 10 7 versus 1 x 10 6 cfu/mL 340 for the engineered consortium. This results in different scales for the self-interaction and 341 interaction parameters across the two consortia, so we normalized the interaction 342 matrices by steady-state dynamics (see Methods) to render the two consortia 343 comparable. We see that the WT consortium has several strong aggregate negative 344
interactions, e.g., mutual negative interactions between E. coli and S. Typhimurium. In 345 contrast, the engineered consortium has aggregate neutral interactions, aside from one 346 strong positive interaction from B. fragilis to S. Typhimurium. 347
348
We can gain insight into the net changes in the quantitative structure of the synthetic 349 Because our model is inferred from longitudinal data, which is relatively sparse and 372 noisy, it is not surprising that some interactions may not be detected. Further, our 373 approach is fully Bayesian and takes into account uncertainty in both the model and 374
measurements. This approach is by design conservative, meaning that it requires 375 strong evidence from the data to formally detect an interaction. Thus, our approach will 376 tend to report the strongest pre-existing or engineering induced interactions, and may 377 miss weaker but still present interactions. Although weak interactions were enhanced by 378 removing any amino acid supplementation in our experiments, these interactions may 379 still fall below our threshold of detection. 380 381
Simulations Based on Realistic Design Constraints Reveal Principles for Stability 382 in Metabolically Cooperative Microbial Consortia 383
We used information from our experiments and data-derived microbial interaction 384 networks to systematically study consortia stability, and gain insight into general design 385 principles. We present these simulations with increasingly realistic design constraints 386
and demonstrate how such constraints lead to different cooperativity regimes. For 387 simplicity of exposition, we assume the four species have identical growth rates , self-388 interaction terms (which is always negative), and identical interactions coefficients 389 ( Figure 5A ). In our first, and least realistic design ( Figure 5B), the growth rate and self-390 interaction terms are kept constant, and only the positive interaction strength is 391 increased. Under these constraints, the carrying capacity and stability of the system 392 increases as the interaction strengths increase, up to the point of system instability. 393
However, such a scenario is unrealistic, because on theoretical grounds, it would allow 394 for the overall carrying capacity of the ecosystem to be arbitrarily increased. Moreover, 395 it is inconsistent with our experimental evidence and data-derived model, which both 396
show a lower overall carrying capacity for the engineered consortia relative to WT. This 397 lowered carrying capacity is driven by both lower growth rates as well as increased 398 negative autoregulation in each species, likely due to the dual burden of auxotrophy and 399
overproduction. 400 401
To match these realistic design constrains, we ran simulations in which increases in 402 cooperative interactions were always accompanied by decreases in intrinsic growth 403 rates and increases in the magnitude of negative autoregulation ( Figure 5C .) We further 404 assumed no interactions prior to engineering. In this scenario, the stability margin 405 cannot be arbitrarily increased, and an engineering design arises, with intermediate 406 cooperation strengths, that optimizes consortium robustness. If cooperation strengths 407 are increased beyond this level, the consortium becomes less stable. Thus, we see that 408 under realistic constraints, there is a trade-off between cooperativity and self-interest in 409 the consortium, with an optimal intermediate. 410
411
We next investigated the impact of pre-existing interactions, an important feature of 412 naturally occurring heterogeneous bacterial species, on stability ( Figure 5D .) In this 413 case, the robustness of the consortium again cannot be arbitrarily increased, and an 414 engineering design that optimizes consortium stability arises. However, in contrast to 415 the case with no interactions prior to engineering ( Figure 5C ), the optimal cooperativity 416 strength is higher. This reflects the fact that engineering must first push pre-existing 417 competitive interactions toward neutrality before pushing interactions into the optimal 418 regime for consortium stability. These results suggest qualitative design principles for 419 engineering cooperative bacterial consortia, and provide tools for future analyses of 420 specific designs. 421 422
Consortia Engineering Increases Population Calance in the Mammalian Gut in a 423
Diet Dependent Manner 424
We investigated the behavior of our consortium in the mammalian gut, using gnotobiotic 425 mice as a controlled yet sufficiently complex environment for evaluation. To investigate 426 the role of amino acid cross-feeding in vivo, we altered amino acid levels in the gut by 427 changing the animal's diet (Ravindran et al., 2016) . Groups of five germfree mice were 428 fed standard or low protein (3%) chow and gavaged with either the WT or engineered 429 consortium ( Figure 6 ). The consortia were allowed to colonize for 10 days, and then 430 stool samples were collected and interrogated via qPCR with species-specific primers. 431
The engineered consortium consistently exhibited greater population evenness in mice 432 that were fed low protein diet compared to the three other groups (Mann-Whitney test; competition for carbohydrate sources, among others. In some instances, we achieved 478 measurable positive interactions, whereas in other cases the negative interactions were 479 neutralized. Of note, our engineered consortia growth is reduced by about 100-fold 480 compared to the WT consortia (Figure 3 a,b) . In essence, we have introduced improved 481 cooperativity into the consortium with concomitant gains in stability and population 482 balance, at the expense of strains' individual fitness. Loss of fitness in this case is likely 483 due to insufficient complementation by the overproducers as shown in our initial system 484 characterization (Figure 2 such hypotheses. In our system, cooperation leads to improved growth of the overall 496 synthetic consortia, but it also promotes continuing survival of each single species 497 through improved population evenness. These two characteristics of our system make it 498 an attractive test-bed to address questions about the evolution of cooperation, which 499 serves both the consortia as a whole and each single species' survival. 500
501
We chose cross-feeding of amino acids as a model of cooperativity, because this 502 approach has been well established and could readily be applied to disparate bacterial 503 species. However, amino acids are also abundant in the animal gut and other 504 environments, raising the possibility that background amino acids levels would simply 505 saturate our synthetic consortium. Remarkably, our consortium demonstrated inducible 506 cooperativity with increased population balance in our gnotobiotic mouse model (Figure  507 6), despite the fact that the germ-free mouse gut contains amino acids from both diet 508 and host sources. This experimental system provides a relatively controlled, but still 509 complex environment, and allows us to readily interpret behavior of the consortia alone 510 without having to consider interactions with a pre-existing microbiota. Of note, all of the 511 strains we used have been shown to individually colonize conventional mice, in some 512 cases without the need for prior antibiotic treatment (Kotula et al., 2014; Riglar et al., 513 2017). However, our approach using amino acid crossfeeding may not translate to a 514 mammalian gut colonized with a pre-existing microbiota. Thus, when extending our 515 results to more complex systems, more orthologous approaches to cooperativity are 516 likely to be necessary to avoid host interference. 517
518
Our computational approach is data-driven and phenomenological, abstracting various 519 types of possible biological interactions (e.g., competition for nutrients, bacteriocin 520 production, syntrophy, etc.) into quantitative pairwise interaction coefficients. This is a 521 different modeling approach than that of many prior auxotroph-overproducer studies, 522 which built detailed metabolic models. These models have not been shown to be 523 reliable for diverse bacteria, such as the Bacteroides spp. in our consortium, in part due 524 to limited knowledge of bacterial metabolism outside of a small number of model 525 organisms. Moreover, as discussed, in a consortium with heterogeneous commensal 526 gut bacteria as members, we expect there to be pre-existing interactions, many of which 527 may not be metabolic. Thus, to gain insights into our consortium, rather than build a 528 bottom-up metabolic model, we infer a phenomenological model from data. Our model 529 is based on stochastic generalized Volterra-Lotka (gLV) dynamics, which is a relatively 530 simple model. More sophisticated models incorporate higher-order interactions or 531 nonlinearities such as saturation effects. However, gLV models have been shown to 532 accurately forecast dynamics in complex host-microbial ecosystems (Bucci et al., 2016) , 533 suggesting that the relatively simple assumption of pairwise quadratic interactions may 534 dominate higher-order and more nonlinear effects. Moreover, reliable inference from 535 data for more complicated models is not possible given the amount of densely sampled 536 time-series data that we could feasibly collect for the present study. 537
538
Overall, we have demonstrated a design, build and test cycle, applicable to engineering 539 microbial consortia that function in the mammalian gut. There is currently interest in 540 developing living bacterial diagnostics and therapeutics for human diseases. The first 541 approach has been to attempt to transfer an uncharacterized microbiota, i.e., fecal 542 microbiota transplants (Boyle, 2015) . Subsequently, there have been efforts to 543 assemble defined collections of naturally occurring commensal bacteria (Atarashi et al.) . 544
While these approaches may work for some diseases, we could anticipate a need for 545 precise and controllable behavior of therapeutics, which will require synthetic biology. 546
Our results help to close this gap, providing new insights into the design principles 547 needed to engineer robust and heterogeneous bacterial consortia. 
Auxotroph engineering 586
For auxotroph generation in the E. coli NGF-1 strain we introduced multiple knockouts 587 by diluting an overnight culture of the donor strain 1:100 LB with 0.2% glucose, 5 mM 591
CaCl2 and 25 mM MgCl2 and incubated for 1-2 hours at 37 °C until slightly turbid. We 592 then added 40 µL P1 lysate and continued growth for 1-3 h at 37 °C while shaking until 593 lysed. Lysate was then filtered with a 20 µm sterile filter and stored in the fridge. For 594 transduction, we harvested 2 mL overnight culture of recipient strain and re-suspended 595 in 2 mL LB with 5 mM CaCl2 and 100 mM MgSO4. We then mixed 100 µL donor lysate 596 with 100 µL recipient, incubated 30 min at 37 °C and added 200 µL sodium citrate (1 M, 597 pH 5.5) and 1 mL LB and incubated for another 1 hr at 37 °C. Cells were harvested, re-598 suspended in 100 µL LB with 100 mM sodium citrate and plated on LB Kan plates (75 599 µg/mL). The transduced kanamycin cassette was then removed using pCP20 according 600 to protocol. We transformed pCP20 via electroporation and transformants were selected 601 on LB agar plates supplemented with 100 µg/mL carbenicillin grown at 30 °C. Single 602 colonies were re-streaked on LB without drugs and incubated for 10 hours at 42 °C. 603
From there, single colonies were re-streaked on LB plates without drugs and grown 604 overnight at 37 °C. Colonies were checked for Carbenicillin, and Kanamycin sensitivity 605 and further confirmed via PCR at respective loci. This procedure was repeated until all 606 knockouts were introduced. 607 608 Engineering of S. Typhimurium LT2 required generation of single knockout strains that 609 contained pKD46 integrated into the genome, which allowed for linear DNA integration 610 using lambda red recombination (Cherepanov and Wackernagel, 1995) . We then 611 introduced the knockouts into the S. Typhimurium strain through sequential P22 612 transduction and pCP20 flipout analogous to E. coli engineering. Single knockout 613 strains were generated by PCR amplifying a Kanamycin resistance cassette from 614 pKD13 generating linear fragments that contained upstream and downstream homology 615 to the gene of interest and the kanamycin cassette with FRT sequences. Fragments 616 were introduced via electroporation and selected on LB agar plates supplemented with 617 50 µg/mL Kanamycin. Sequential P22 transduction and pCP20 flip-out was essentially 618 performed as described above for P1 transduction but lysis was done overnight. 619
620
For knockout generation of both B. theta and B. fragilis, we used pExchange KO vectors 621 as described (Mimee et al., 2015) . Briefly, we introduced 750 bp flanking regions for 622 genes of interest adjacent to each other into the vector. The vector contains an 623 erythromycin resistance positive marker and a thymidine kinase as counter selection 624 marker. Cloning was done in pir + E. coli strains and vectors were transferred to MFDpir 625 for conjugation (Ferrières et al., 2010) . Conjugation was done according to protocol with 626 minor changes. In brief, five drops of overnight culture of E. coli donor was inoculated in 627 LB supplemented with 300 µM Diamino pimelic acid (DAP) and five drops of recipient 628 overnight culture was inoculated in 50 mL basal media. Both cultures were grown for 629 about 2 hr (E. coli aerobically, Bacteroides spp. anaerobically) until E. coli culture was 630 well turbid and Bacteroides culture just slightly turbid. Subsequently, 9 mL recipient and 631 3 mL donor were combined and spun down for 10 min at 4000 rpm together. The pellet 632 was re-suspended in 100 µL fresh basal media with 300 µM DAP and pipetted on basal 633 media agar plates without cysteine and supplemented with 300 µM DAP. The cells were 634 incubated at 37 °C aerobically face up for up to 20 hr, scraped off and re-suspended in 635 10% glycerol. Dilutions were plated on basal-agar plates supplemented with 10 µg/mL 636 erythromycin and incubated at 37 °C anaerobically for 2-3 days. Single colonies were 637 re-streaked in the presence of erythromycin and grown for another 2 days. 10 single 638 colonies were inoculated in basal media without drug and grown overnight. 500 µL of 639 each culture was mixed, spun down and re-suspended in 10% glycerol. We then plated 640 different dilutions on basal media plates supplemented with 5-fluoro-2-deoxy-uridine 641 (FuDR) (200 µg/mL) and incubated at 37 °C anaerobically for 3 days. Knockouts were 642 verified via PCR. This procedure was repeated multiple times to obtain the multiple 643 auxotroph strains. 644
645
Overproducer selection 646
Overproducers were generated by selecting for mutants that could grow on minimal 647 media agar plates supplemented with anti-metabolites (E. coli: 5 mg/mL Norleucine for 648 Met overproduction; S. Typhimurium: > 0.7 mg/mL beta-(2-thiazolyl)-DL-alanine for His 649 overproduction; B. theta: 50 µg/mL 4-methyl tryptophan for Trp overproduction; B. 650 fragilis: 80 µg/mL Canavinine for Arg overproduction). Single colonies that showed 651 halos were re-streaked and overproduction was measured using a bioassay. In brief, for 652 screening of overproducing mutants the isolated strains were grown overnight at 37 °C 653 shaking aerobically (for E. coli and S. typhimurium) or anaerobically without agitation 654 (for Bacteroides spp.). Supernatant was harvested, diluted 1:1 with fresh media, and E. 655 coli auxotrophs were inoculated and their growth was recorded after 24 hr. For E. coli 656 NGF-1 overproducers, we used a S. Typhimurium auxotroph instead, since its colicin 657 production prevented the E. coli biosensor from growing. Confirmed overproducers 658
were further quantified using LC-MS. 659 660
LC-MS for Overproduction Measurements 661
To quantitate amino acid levels in overproducer supernatants, a standard curve was 662 obained using freshly prepared amino acid standards dissolved in growth media (1mM, 663 500 uM, 100 uM, 50 uM, 10 uM of L. Methionine, L/Histidine, L-Tryptophan, L-Arginine 664 each). To prepare for HPLC-MS analysis, 0.5 mL sample or standard were added to 665 1.5 mL ice-cold methanol and incubated on ice for 10 min. The mixture was centrifuged 666
for 5 min at 15,000 rpm and 500 µL supernatant was vacuum concentrated and re-667 suspended in 50 µL methanol. Samples were kept on ice or at 4°C. HPLC-MS analysis 668 of standards and extracts was carried out using an Agilent 1260 Infinity HPLC system 669 equipped with an Agilent Eclipse Plus C18 (100 × 4.6 mm, particle size 3.5 mm, flow End (PE150) reagents. Sequences were analyzed for SNPs using Geneious software 687 and published genome sequences (E. coli: CP016007.1; S. typhimurium: NC_003197; 688 B. theta: AE015928; B. fragilis: NC_016776) (Table S1) . 689 690
Growth and Media Conditions 691
All basal media and co-culture media was pre-incubated for at least 24 hr anaerobically 692 before use. Bacteroides spp. were inoculated from glycerol stock into basal media, 693 grown overnight and 400 µL was inoculated in 5 mL basal and grown 2 hr anaerobically. 694
Cells were spun down, washed twice in PBS and diluted in growth media as described 695 for each experiment in Results. E. coli and S. Typhimurium were inoculated from 696 glycerol stock into LB and grown overnight at 37 °C while shaking. 100 µL of culture 697 was then inoculated into pre-incubated LB and grown anaerobically for 2 hr, diluted, 698 washed in PBS and diluted into co-culture media as described. Co-culture media 699 consisted of modified M9 salts (0.2 g/L Na2HPO4, 90 mg/L KH2PO4, 30 mg/L NH4Cl, 15 700 mg/L NaCl), 1 mM MgSO4, 10 µg/mL heme, 0.1 mM CaCl2, 1 µg/mL Niacinamide, 701 vitamin B12 and thiamine, 400 µg/mL L-cysteine, 0.3% bicarbonate buffer, 2.5 ng/mL 702 vitamin K, 2 µg/mL FeSO4*7H2O and carbon sources and amino acid supplementation 703 as described in Results. 704
705
Multiplex qPCR 706
We designed strain specific primer/probe-fluorophore pairs according to IDT protocol 707 (Table S2 ). We chose strain specific genes by multiple genome alignment between the 708 strain of interest, the other consortia members and closely related strains using Mauve 709 (Darling et al., 2004) . Multiplex qPCR was used to quantify each strain in co-culture by 710 using a standard curve obtained by plating late log phase cultures grown in rich media. 711
In brief, each strain was grown from overnight culture for ~5 hours until about OD of 1. 712 Cells were then counted by plating. Cultures were mixed, diluted and frozen at -80 °C 713 for use as standard curve. Samples were diluted 1:10 in ddH2O and snap-frozen in 714 liquid nitrogen and stored at least overnight at -80 °C. Growth curve and sample were 715 both thawed together and prepared in a 5 µL Primetime Mastermix (IDT) with 1 µL 716
Primer/Probe mixture (final concentrations: 100 nM for primers and 50 nM for probes). 717
The qPCR was run with the following program: 20 min at 98 µC (to boil the cells and 718 denature gDNA), followed by 40 cycles of 60 °C and 98 °C. 719 720
Calculation of Normalized Entropy (Pielou's Evenness) and Hellinger Distance 721
Normalized entropy (Pielou's evenness) was calculated according to the given formula: 722
ln ( ) 724 725
Where pi refers to the population ratio of a given strain in the consortium of four strains. 726 S is the number of species. 727
Hellinger distance was used as a metric for comparing consortia relative abundances. 
732
Where pi and qi are the ratios of each strain in the consortium in two different conditions. 733 734 735
Pairwise Supernatant Experiment 736
Overproducers and WT strains were grown overnight anaerobically at 37 °C in co-737 culture media and supernatant was harvested and sterile filtered. Auxotrophs were 738 prepared as described in Media and Growth conditions and inoculated in media that 739 contained 50% fresh co-culture media and 50% spent supernatant. OD600 was 740 measured after 24 hr growth anaerobically at 37 °C. 741
742
In vivo Experiments 743
Adult (6-8 weeks) male Swiss Webster germ free mice bred in house at the 744 Massachusetts Host-Microbiome Center were used. Animals were fed either on 745 standard chow in the facility for the entire experiment, or on low-protein diet (3% custom 746 diet, envigo, doubly irradiated) beginning 10 days prior to the experiment and continuing 747 for its duration. To prepare bacteria for gavage, we grew each strain to mid-log phase, 748 
Bayesian dynamical systems inference 795
Our dynamical systems model and associated inference algorithm is a version of our 796 previously published method (Gibson and Gerber, 2018) that we have customized for 797 this study. Briefly, our model is based on continuous time stochastic gLV dynamics as 798 described in Results. We approximate these dynamics with a first order Euler 799 integration of step size Δ ,ℓ 800
Our model is fully Bayesian, with the inference goal being to learn the posterior 802 probability distribution over both the model parameters as well as the qualitative 803 interaction structure graph. To model the interaction structure graph, we use indicator 804 variables , , which indicate the presence or absence of the edge from species i to j in 805 the graph. The resulting conditional distribution for dynamics is then: 806
Where ,ℓ is the variance for the Brownian motion. Our measurements of microbial 809 abundances are captured by the observed variable . We introduce an auxiliary variable 810 that enables efficient inference of a relaxed system (see Gibson and Gerber, 2018 for 811
We estimate the measurement variance , ,ℓ directly from qPCR technical replicates, 816 obtaining = 10 10 , and = 10 6 . The prior probability distributions for the indicator 817 variables, the growth rates, and the interactions terms as defined below: 818
Note that our prior for z, the indicator variables for presence or absence of interaction 822 edges is set to indicate maximum uncertainty, e.g., no a priori assumption about the 823 presence or absence of an interaction. The variance parameters in our model that are 824 not a-priori fixed or estimated from technical replicates have the following conjugate 825
Our parameterization of the Inv − Χ 2 is as follows 830
which is sometimes referred to as the Scale − Inv − Χ 2 distribution, because it has two 832 parameters, number of degrees of freedom , and scale parameter . In our model 833 
